Home > Pressrelease > Drug-eluting Balloon Catheters Market size to surpass $1 billion by 2030

Drug-eluting Balloon Catheters Market size to surpass $1 billion by 2030

  • Published Date: November 4, 2022

Drug-eluting Balloon Catheters Market size is anticipated to exceed USD 1 billion by 2030, cites the latest report by Global Market Insights Inc.

Increasing technological advancements in modality and devices are elevating the accuracy of drug-eluting balloon catheters, which is largely shaping the industry outlook. These advancements offer an alternative non-stent method for treating atherosclerotic lesions, in-stent restenosis, and peripheral artery disease among others. Concurrently, many leading industry giants are further shaping the market landscape by emphasizing on innovating minimally invasive PTCA balloon catheters to provide patient-friendly treatment options.

Increasing cardiac disorders to fuel peripheral artery disease DCB catheters segment progression

DCB catheters market from peripheral artery disease drug-coated balloon catheters segment generated revenues of over USD 250 million in 2021, driven by the global rise in co-morbid conditions such as peripheral and cardiac disorders.

Browse key industry insights spread across 159 pages with 221 market data tables & 14 figures & charts from the report, “Drug-Eluting Balloon Catheters Market Size By Product (Coronary Artery Disease Drug-Eluting Balloon Catheters {Paclitaxel, Sirolimus}, Peripheral Vascular Disease Drug-Eluting Balloon Catheters {Paclitaxel, Sirolimus}), By End-use (Hospitals and Clinics, Ambulatory Surgical Centers, Catheterization Laboratories) Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 – 2030” in detail along with the table of contents:

Rising need for surgical interventions to foster hospitals and clinics segment expansion

Hospitals and clinics segment amassed over USD 260 million in 2021. The rising occurrence of chronic disorders requiring surgical interventions will continue to fuel segmental revenues. A new 2022 report by Frontiers on Cardiovascular Epidemiology and Prevention, stated that over 113.44 million people were suffering from peripheral artery disease across the globe in 2019, leading to more than 74 thousand deaths.

High preference for minimally invasive surgical procedures to drive Europe market size

Europe drug-eluting balloon catheters market is anticipated to surpass USD 320 million by 2030, driven by the growing focus of industry players towards delivering effective treatment services. Additionally, rising patient inclination towards minimally invasive surgical procedures is also shaping the regional outlook. Meanwhile, implementation of supportive initiatives across the bloc, to strengthen the healthcare infrastructure and raise awareness about different chronic diseases, is proving beneficial for the market as well.

Product innovations to define the market landscape

Leading DCB catheters industry contenders include Medtronic, Lepu Medical Technology (Beijing)Co Ltd., BD Interventional, MedAlliance, Boston Scientific Corporation, and others. Many are investing towards innovations to enhance their product portfolios.

Authors: Sumant Ugalmugle, Rupali Swain